Detailed information for compound 140039

Basic information

Technical information
  • TDR Targets ID: 140039
  • Name: N-[(2-chlorophenyl)methyl]-3-(2-dimethylamino ethyl)-5-[2-(4,4-dimethyl-2,5-dioxoimidazolid in-1-yl)ethyl]-1H-indole-2-carboxamide
  • MW: 510.028 | Formula: C27H32ClN5O3
  • H donors: 3 H acceptors: 3 LogP: 3.84 Rotable bonds: 10
    Rule of 5 violations (Lipinski): 2
  • SMILES: CN(CCc1c([nH]c2c1cc(CCN1C(=O)NC(C1=O)(C)C)cc2)C(=O)NCc1ccccc1Cl)C
  • InChi: 1S/C27H32ClN5O3/c1-27(2)25(35)33(26(36)31-27)14-11-17-9-10-22-20(15-17)19(12-13-32(3)4)23(30-22)24(34)29-16-18-7-5-6-8-21(18)28/h5-10,15,30H,11-14,16H2,1-4H3,(H,29,34)(H,31,36)
  • InChiKey: GDRCZYGSCSTOEU-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • N-[(2-chlorophenyl)methyl]-3-(2-dimethylaminoethyl)-5-[2-(4,4-dimethyl-2,5-dioxo-imidazolidin-1-yl)ethyl]-1H-indole-2-carboxamide
  • N-[(2-chlorophenyl)methyl]-3-(2-dimethylaminoethyl)-5-[2-(4,4-dimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]-1H-indole-2-carboxamide
  • N-(2-chlorobenzyl)-5-[2-(2,5-diketo-4,4-dimethyl-imidazolidin-1-yl)ethyl]-3-(2-dimethylaminoethyl)-1H-indole-2-carboxamide

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus granulosus histone acetyltransferase KAT2B 0.0045 0.1215 0.2364
Trichomonas vaginalis cat eye syndrome critical region protein 2, cscr2, putative 0.0045 0.1215 0.3924
Trypanosoma brucei apurinic/apyrimidinic endonuclease, putative 0.0022 0.0333 0.1277
Trichomonas vaginalis CMGC family protein kinase 0.006 0.1796 0.6505
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.134 0.2527
Toxoplasma gondii histone lysine acetyltransferase GCN5-B 0.0045 0.1215 0.3924
Trichomonas vaginalis pantothenate kinase, putative 0.008 0.2581 1
Mycobacterium ulcerans exodeoxyribonuclease III protein XthA 0.0022 0.0333 1
Echinococcus multilocularis gcn5proteinral control of amino acid synthesis 0.0152 0.5302 1
Entamoeba histolytica acetyltransferase, GNAT family 0.0041 0.1074 0.3293
Mycobacterium tuberculosis Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) 0.0022 0.0333 0.5
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative 0.0048 0.134 0.1336
Giardia lamblia Kinase, CMGC MAPK 0.006 0.1796 0.6505
Trichomonas vaginalis pantothenate kinase, putative 0.008 0.2581 1
Brugia malayi hypothetical protein 0.0028 0.0599 0.0595
Trypanosoma cruzi pantothenate kinase subunit, putative 0.008 0.2581 0.9396
Trichomonas vaginalis CMGC family protein kinase 0.006 0.1796 0.6505
Trichomonas vaginalis pantothenate kinase, putative 0.008 0.2581 1
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.134 0.2527
Trichomonas vaginalis CMGC family protein kinase 0.006 0.1796 0.6505
Onchocerca volvulus Huntingtin homolog 0.0275 1 1
Leishmania major pantothenate kinase subunit, putative 0.0085 0.2747 1
Giardia lamblia Histone acetyltransferase GCN5 0.0041 0.1074 0.3293
Plasmodium falciparum pantothenate kinase 1, putative 0.008 0.2581 1
Trypanosoma cruzi mitogen activated protein kinase 2, putative 0.006 0.1796 0.6532
Schistosoma mansoni pantothenate kinase 0.008 0.2581 0.4868
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.006 0.1796 0.6532
Plasmodium vivax histone acetyltransferase GCN5, putative 0.0045 0.1215 0.3924
Brugia malayi hypothetical protein 0.0018 0.0214 0.021
Trypanosoma brucei PAB1-binding protein , putative 0.0028 0.0599 0.2308
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0048 0.134 0.2607
Plasmodium falciparum ataxin-2 like protein, putative 0.0028 0.0599 0.1183
Trypanosoma brucei mitogen activated protein kinase 4, putative 0.006 0.1796 0.6952
Echinococcus multilocularis mitogen activated protein kinase 3 0.006 0.1796 0.3387
Schistosoma mansoni ap endonuclease 0.0022 0.0333 0.0628
Echinococcus granulosus mitogen activated protein kinase 0.006 0.1796 0.3494
Trichomonas vaginalis conserved hypothetical protein 0.0046 0.1285 0.4235
Trypanosoma cruzi PAB1-binding protein , putative 0.0028 0.0599 0.2169
Echinococcus granulosus DNA apurinic or apyrimidinic site lyase 0.0022 0.0333 0.0648
Giardia lamblia Pantothenate kinase 4 0.008 0.2581 1
Wolbachia endosymbiont of Brugia malayi exonuclease III 0.0022 0.0333 0.5
Trichomonas vaginalis pantothenate kinase, putative 0.008 0.2581 1
Loa Loa (eye worm) exodeoxyribonuclease III family protein 0.0022 0.0333 0.0329
Entamoeba histolytica pantothenate kinase 1, putative 0.008 0.2581 1
Schistosoma mansoni serine/threonine protein kinase 0.006 0.1796 0.3387
Plasmodium falciparum ataxin-2 like protein, putative 0.0028 0.0599 0.1183
Plasmodium falciparum histone acetyltransferase GCN5 0.0041 0.1074 0.3293
Echinococcus granulosus pantothenate kinase 4 0.008 0.2581 0.5022
Trypanosoma brucei pantothenate kinase subunit, putative 0.008 0.2581 1
Brugia malayi pantothenate kinase family protein 0.008 0.2581 0.2578
Echinococcus granulosus histone acetyltransferase KAT2B 0.0148 0.514 1
Trypanosoma brucei protein kinase, putative 0.006 0.1796 0.6952
Plasmodium falciparum pantothenate kinase 2, putative 0.0034 0.0809 0.2116
Onchocerca volvulus Huntingtin homolog 0.0275 1 1
Brugia malayi acetyltransferase, GNAT family protein 0.0152 0.5302 0.53
Echinococcus granulosus guanine nucleotide binding protein Gs subunit 0.0048 0.134 0.2607
Toxoplasma gondii histone lysine acetyltransferase GCN5-A 0.0045 0.1215 0.3924
Loa Loa (eye worm) hypothetical protein 0.0275 1 1
Echinococcus granulosus mitogen activated protein kinase 3 0.006 0.1796 0.3494
Treponema pallidum exodeoxyribonuclease (exoA) 0.0022 0.0333 0.5
Trichomonas vaginalis pantothenate kinase, putative 0.008 0.2581 1
Loa Loa (eye worm) hypothetical protein 0.0275 1 1
Brugia malayi MAP kinase sur-1 0.006 0.1796 0.1792
Loa Loa (eye worm) hypothetical protein 0.0028 0.0599 0.0595
Toxoplasma gondii pantothenate kinase 0.0034 0.0809 0.2116
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) 0.0048 0.134 0.2527
Echinococcus multilocularis DNA (apurinic or apyrimidinic site) lyase 0.0022 0.0333 0.0628
Toxoplasma gondii CMGC kinase, MAPK family (ERK) MAPK-1 0.006 0.1796 0.6505
Loa Loa (eye worm) CMGC/MAPK/ERK1 protein kinase 0.006 0.1796 0.1792
Trichomonas vaginalis bromodomain-containing protein, putative 0.0045 0.1215 0.3924
Trypanosoma cruzi apurinic/apyrimidinic endonuclease 0.0022 0.0333 0.12
Leishmania major mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 0.006 0.1796 0.6532
Trypanosoma cruzi mitogen activated protein kinase 4, putative 0.006 0.1796 0.6532
Loa Loa (eye worm) acetyltransferase 0.0152 0.5302 0.53
Leishmania major apurinic/apyrimidinic endonuclease-redox protein 0.0022 0.0333 0.12
Schistosoma mansoni pantothenate kinase 0.008 0.2581 0.4868
Trypanosoma cruzi PAB1-binding protein , putative 0.0028 0.0599 0.2169
Trypanosoma cruzi apurinic/apyrimidinic endonuclease, putative 0.0022 0.0333 0.12
Trypanosoma cruzi pantothenate kinase subunit, putative 0.0085 0.2747 1
Loa Loa (eye worm) pantothenate kinase 0.008 0.2581 0.2578
Leishmania major mitogen activated protein kinase, putative,map kinase, putative 0.006 0.1796 0.6532
Toxoplasma gondii LsmAD domain-containing protein 0.0028 0.0599 0.1183
Plasmodium vivax pantothenate kinase, putative 0.008 0.2581 1
Leishmania major hypothetical protein, conserved 0.0028 0.0599 0.2169
Brugia malayi exodeoxyribonuclease III family protein 0.0022 0.0333 0.0329
Trichomonas vaginalis CMGC family protein kinase 0.006 0.1796 0.6505
Trypanosoma cruzi mitogen-activated protein kinase 11, putative 0.006 0.1796 0.6532
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0048 0.134 0.2527
Plasmodium vivax hypothetical protein, conserved 0.0034 0.0809 0.2116
Plasmodium vivax ataxin-2 like protein, putative 0.0028 0.0599 0.1183
Echinococcus multilocularis mitogen activated protein kinase 0.006 0.1796 0.3387
Schistosoma mansoni ap endonuclease 0.0022 0.0333 0.0628
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit 0.0048 0.134 0.2527
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain 0.0048 0.134 0.1336
Toxoplasma gondii fumble protein 0.008 0.2581 1
Schistosoma mansoni gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 0.0152 0.5302 1
Echinococcus multilocularis pantothenate kinase 4 0.008 0.2581 0.4868

Activities

Activity type Activity value Assay description Source Reference
pKB (binding) = 5.35 Alpha-1 adrenergic receptor affinity using ring preparations of rabbit thoracic aorta (RbTA). ChEMBL. 10411472
pKB (binding) = 5.81 Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV) ChEMBL. 10411472
pKB (binding) = 5.35 Alpha-1 adrenergic receptor affinity using ring preparations of rabbit thoracic aorta (RbTA). ChEMBL. 10411472
pKB (binding) = 5.81 Binding affinity against vascular 5-hydroxytryptamine 1B receptor, measured using ring preparations of rabbit saphenous vein (RbSV) ChEMBL. 10411472

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.